• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.胃癌:流行病学、发病机制、分子遗传学和化学预防的综述。
World J Gastrointest Oncol. 2012 Jul 15;4(7):156-69. doi: 10.4251/wjgo.v4.i7.156.
2
Genetic pathways of two types of gastric cancer.两种类型胃癌的遗传通路。
IARC Sci Publ. 2004(157):327-49.
3
9th Seah Cheng Siang Memorial Lecture: gastric cancer--where are we now?第九届 Seah Cheng Siang 纪念讲座:胃癌——我们目前的进展如何?
Ann Acad Med Singap. 1999 Nov;28(6):881-9.
4
[Could Helicobacter pylori treatment reduce stomach cancer risk?].幽门螺杆菌治疗能降低胃癌风险吗?
Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 2):440-52.
5
Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.幽门螺杆菌感染和高盐饮食处理的小鼠胃肿瘤模型的基因表达分析:鉴定 CD177 作为胃癌患者的一个新的预后因素。
BMC Gastroenterol. 2013 Jul 30;13:122. doi: 10.1186/1471-230X-13-122.
6
Helicobacter pylori Infection and Dietary Factors Act Synergistically to Promote Gastric Cancer.幽门螺杆菌感染与饮食因素协同作用促进胃癌发生。
Asian Pac J Cancer Prev. 2016;17(3):917-21. doi: 10.7314/apjcp.2016.17.3.917.
7
Epidemiology of gastric cancer in relation to diet and Helicobacter pylori infection.与饮食和幽门螺杆菌感染相关的胃癌流行病学
J Gastroenterol Hepatol. 1998 Nov;13(S3):S166-S172. doi: 10.1111/j.1440-1746.1998.tb01871.x.
8
Gastric cáncer: Overview.胃癌:概述。
Colomb Med (Cali). 2013 Sep 30;44(3):192-201. eCollection 2013 Jul.
9
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?在小鼠模型中对幽门螺杆菌相关胃癌发生的化学预防:这可行吗?
J Biochem Mol Biol. 2003 Jan 31;36(1):82-94. doi: 10.5483/bmbrep.2003.36.1.082.
10
Risk factors in gastric cancer.胃癌的危险因素。
Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):302-8.

引用本文的文献

1
Ecological associations between gastric acid suppressant use and gastrointestinal cancer incidence: a three-decade global study.胃酸抑制剂使用与胃肠道癌症发病率之间的生态关联:一项为期三十年的全球研究。
Ir J Med Sci. 2025 Sep 13. doi: 10.1007/s11845-025-04085-1.
2
ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment.ATR-CHK1轴抑制剂在胃癌治疗中的应用
Int J Mol Sci. 2025 Aug 9;26(16):7709. doi: 10.3390/ijms26167709.
3
Cell-in-cell associated lncRNA signature predicts prognosis and immunotherapy response in gastric cancer.细胞内细胞相关的长链非编码RNA特征预测胃癌的预后和免疫治疗反应。
Front Oncol. 2025 Jul 8;15:1597187. doi: 10.3389/fonc.2025.1597187. eCollection 2025.
4
The anticancer potential of Origanum onites L. in gastric cancer through epigenetic alterations.牛至通过表观遗传改变对胃癌的抗癌潜力。
BMC Complement Med Ther. 2025 Jul 2;25(1):220. doi: 10.1186/s12906-025-04942-7.
5
Sequence Variation in X-ray Cross Complimenting (XRCC4, XRCC5, XRCC6 and XRCC7) Genes and the Risk of Gastrointestinal Cancer in South-Western Maharashtra: A Hospital Based Case-Control Study.马哈拉施特拉邦西南部X射线交叉互补(XRCC4、XRCC5、XRCC6和XRCC7)基因的序列变异与胃肠道癌风险:一项基于医院的病例对照研究
Asian Pac J Cancer Prev. 2025 May 1;26(5):1571-1579. doi: 10.31557/APJCP.2025.26.5.1571.
6
Exploring the Role of Mitochondrial Sirtuin 3 Gene in Gastric Cancer Risk Based on SNP Analysis and LORD-Q Assay.基于单核苷酸多态性分析和LORD-Q检测探究线粒体沉默调节蛋白3基因在胃癌风险中的作用
Biochem Genet. 2025 Apr 28. doi: 10.1007/s10528-025-11119-x.
7
Understanding the Role of Rho GTPase Activating Protein and Bone Marrow Kinase X: A Novel Target in Gastric Cancer Treatment.了解Rho GTP酶激活蛋白和骨髓激酶X的作用:胃癌治疗的新靶点
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):725-733. doi: 10.31557/APJCP.2025.26.3.725.
8
Silencing of RNFT2 suppresses cell proliferation and migration through mTORC1 signaling pathway in gastric cancer.RNFT2沉默通过mTORC1信号通路抑制胃癌细胞的增殖和迁移。
Amino Acids. 2025 Mar 18;57(1):19. doi: 10.1007/s00726-025-03449-2.
9
CircRNAs: A promising target for intervention regarding glycolysis in gastric cancer.环状RNA:胃癌糖酵解干预的一个有前景的靶点。
Heliyon. 2024 Jul 15;10(14):e34658. doi: 10.1016/j.heliyon.2024.e34658. eCollection 2024 Jul 30.
10
Inhibition of USP22 by miR-200b-5p represses gastric cancer cell proliferation and migration by targeting the NF-κB signaling pathway.miR-200b-5p对USP22的抑制作用通过靶向NF-κB信号通路抑制胃癌细胞的增殖和迁移。
Acta Biochim Biophys Sin (Shanghai). 2024 Dec 20. doi: 10.3724/abbs.2024231.

本文引用的文献

1
Genetic aspects of gastric cancer instability.胃癌不稳定性的遗传学方面
ScientificWorldJournal. 2012;2012:761909. doi: 10.1100/2012/761909. Epub 2012 Apr 19.
2
Gastric cancer carcinogenesis and tumor progression.胃癌的致癌作用及肿瘤进展。
Ann Ital Chir. 2012 May-Jun;83(3):172-6.
3
Clinical potential of DNA methylation in gastric cancer: a meta-analysis.胃癌中 DNA 甲基化的临床潜力:一项荟萃分析。
PLoS One. 2012;7(4):e36275. doi: 10.1371/journal.pone.0036275. Epub 2012 Apr 27.
4
Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer.循环游离人端粒酶逆转录酶 mRNA 在血浆中的表达及其对胃癌的诊断和预后价值。
Int J Clin Oncol. 2013 Jun;18(3):478-86. doi: 10.1007/s10147-012-0405-9. Epub 2012 Apr 12.
5
Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up.水果和蔬菜摄入量与胃腺癌风险:欧洲癌症前瞻性调查与营养(EPIC-EURGAST)研究的重新分析,随访时间更长。
Int J Cancer. 2012 Dec 15;131(12):2910-9. doi: 10.1002/ijc.27565. Epub 2012 Apr 26.
6
Cancer mortality in India: a nationally representative survey.印度的癌症死亡率:一项全国代表性调查。
Lancet. 2012 May 12;379(9828):1807-16. doi: 10.1016/S0140-6736(12)60358-4. Epub 2012 Mar 28.
7
Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis.慢性浅表性胃炎患者胃黏膜中幽门螺杆菌感染和未感染患者的基因表达谱分析。
PLoS One. 2012;7(3):e33030. doi: 10.1371/journal.pone.0033030. Epub 2012 Mar 16.
8
Tobacco use is associated with increased recurrence and death from gastric cancer.吸烟与胃癌的复发和死亡增加有关。
Ann Surg Oncol. 2012 Jul;19(7):2088-94. doi: 10.1245/s10434-012-2230-9. Epub 2012 Mar 7.
9
Multifactorial etiology of gastric cancer.胃癌的多因素病因
Methods Mol Biol. 2012;863:411-35. doi: 10.1007/978-1-61779-612-8_26.
10
Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies.习惯性盐摄入量与胃癌风险:前瞻性研究的荟萃分析。
Clin Nutr. 2012 Aug;31(4):489-98. doi: 10.1016/j.clnu.2012.01.003. Epub 2012 Jan 31.

胃癌:流行病学、发病机制、分子遗传学和化学预防的综述。

Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

机构信息

Siddavaram Nagini, Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.

出版信息

World J Gastrointest Oncol. 2012 Jul 15;4(7):156-69. doi: 10.4251/wjgo.v4.i7.156.

DOI:10.4251/wjgo.v4.i7.156
PMID:22844547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3406280/
Abstract

Carcinoma of the stomach is still the second most common cause of cancer death worldwide, although the incidence and mortality have fallen dramatically over the last 50 years in many regions. The incidence of gastric cancer varies in different parts of the world and among various ethnic groups. Despite advances in diagnosis and treatment, the 5-year survival rate of stomach cancer is only 20 per cent. Stomach cancer can be classified into intestinal and diffuse types based on epidemiological and clinicopathological features. The etiology of gastric cancer is multifactorial and includes both dietary and nondietary factors. The major diet-related risk factors implicated in stomach cancer development include high content of nitrates and high salt intake. Accumulating evidence has implicated the role of Helicobacter pylori (H. pylori) infection in the pathogenesis of gastric cancer. The development of gastric cancer is a complex, multistep process involving multiple genetic and epigenetic alterations of oncogenes, tumor suppressor genes, DNA repair genes, cell cycle regulators, and signaling molecules. A plausible program for gastric cancer prevention involves intake of a balanced diet containing fruits and vegetables, improved sanitation and hygiene, screening and treatment of H. pylori infection, and follow-up of precancerous lesions. The fact that diet plays an important role in the etiology of gastric cancer offers scope for nutritional chemoprevention. Animal models have been extensively used to analyze the stepwise evolution of gastric carcinogenesis and to test dietary chemopreventive agents. Development of multitargeted preventive and therapeutic strategies for gastric cancer is a major challenge for the future.

摘要

胃癌仍然是全球第二大常见癌症死因,尽管在过去 50 年中,许多地区的发病率和死亡率已大幅下降。胃癌的发病率在世界不同地区和不同种族之间存在差异。尽管在诊断和治疗方面取得了进展,但胃癌的 5 年生存率仅为 20%。胃癌可根据流行病学和临床病理特征分为肠型和弥漫型。胃癌的病因是多因素的,包括饮食和非饮食因素。与胃癌发展相关的主要饮食相关危险因素包括硝酸盐含量高和高盐摄入。越来越多的证据表明,幽门螺杆菌(H. pylori)感染在胃癌的发病机制中起作用。胃癌的发生是一个复杂的、多步骤的过程,涉及癌基因、肿瘤抑制基因、DNA 修复基因、细胞周期调节剂和信号分子的多个遗传和表观遗传改变。一个合理的胃癌预防计划包括摄入含有水果和蔬菜的均衡饮食、改善卫生和卫生条件、筛查和治疗 H. pylori 感染以及随访癌前病变。饮食在胃癌病因学中起着重要作用,这为营养化学预防提供了可能性。动物模型已被广泛用于分析胃癌发生的逐步演变,并测试饮食化学预防剂。开发针对胃癌的多靶点预防和治疗策略是未来的主要挑战。